MELISSA REILLY: Open Payments
NPI 1013426261 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 13 payments from 5 companies in 2025. Trend: 2023 $425 · 2024 $319 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $170 |
| Lilly USA, LLC | 2 | $47 |
| Ardelyx, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| VIVUS LLC | 1 | $22 |
Products named: Wegovy, MOUNJARO, IBSRELA, RECORLEV, QSYMIA, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
